Abstract
In this paper I review the present condition of the regeneration medicine research using pluripotency and a somatic stem cell, and I describe the subject of the science and technology policy in Japan towards realization of regeneration medicine. The Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) supported research promotion by the prompt action in 2007 when establishment of the iPS cell was reported by Shinya Yamanaka. Although the hospitable support of the Japanese government to an iPS cell is continued still now, there are some problems in respect of the support to other stem cell researches, and industrialization of regeneration medicine. In order to win a place in highly competitive area of investigation, MEXT needs to change policy so that funds may be widely supplied also to stem cell researches other than iPS cell research.
| Original language | English |
|---|---|
| Pages (from-to) | 2251-2256 |
| Number of pages | 6 |
| Journal | Nihon rinsho. Japanese journal of clinical medicine |
| Volume | 69 |
| Issue number | 12 |
| Publication status | Published - 12-2011 |
| Externally published | Yes |
All Science Journal Classification (ASJC) codes
- General Medicine